A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies

NCT01793870 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic, Cardiovascular

Interventions

DRUG: Tab carvedilol 25 mg
DRUG: Tab carvedilol 6.25 mg
DRUG: Powder carvedilol up to 2.5 mg

Sponsor

GlaxoSmithKline